Tumor-preferential induction of immune responses and epidermal cell death in actinic keratoses by ingenol mebutate

HIGHLIGHTS

• who: Steffen Emmert and collaborators from the Department of Dermatology, Venereology and Allergology, University Medical Center Göttingen, Göttingen, Germany, LEO Pharma A/S, Ballerup, Denmark have published the Article: Tumor-Preferential Induction of Immune Responses and Epidermal Cell Death in Actinic Keratoses by Ingenol Mebutate, in the Journal: PLOS ONE | DOI:10.1371/journal.pone [0160096]. September 9, 2016 of December/29,/2015
• what: The aim of the study was the first-in-man investigation of the biological and pharmacodynamic activity of ingenol mebutate, representing a novel class of anti-tumoral agents, in . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.